NCT02150473View on ClinicalTrials.gov

The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 14, 2017

Study Completion Date

September 14, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Adalimumab

adalimumab 40 mg every other week in combination with MTX for 24 weeks

DRUG

Placebo

Placebo the same amount as adalimumab

Trial Locations (1)

40225

Universitätsklinikum Düsseldorf, Düsseldorf

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Heinrich-Heine University, Duesseldorf

OTHER